Article
Coherus BioSciences to launch Humira biosimilar at 85% discount
Rating:
0.0
Views:
76
Likes:
1
Library:
1
Coherus BioSciences Inc said on Thursday it plans to launch a biosimilar of AbbVie Inc's Humira in July at a list price of $995 per carton, representing a discount of about 85% from the blockbuster arthritis drug.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value